Skip to content

Insider · CIK 0001799659

Ann Beal Salamone

director

Files at SMTI (Sanara MedTech Inc.). First filing -, latest -.

In brief

Ann Beal Salamone files SEC Form 4 as director at SMTI (Sanara MedTech Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Ann Beal Salamone has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 4, 2026SMTI
Sanara MedTech Inc.
AGrant or award
Common Stock
+4,154$0.00$026,858Jun 5, 2026
May 22, 2025SMTI
Sanara MedTech Inc.
AGrant or award
Common Stock
+2,809$0.00$022,704May 27, 2025
Jun 12, 2024SMTI
Sanara MedTech Inc.
AGrant or award
Common Stock
+2,949$0.00$019,895Jun 14, 2024

Questions about Ann Beal Salamone

Answered from the filings on this page, as of the latest one.

Is Ann Beal Salamone buying or selling?

Ann Beal Salamone has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Ann Beal Salamone's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ann Beal Salamone has 0.

Where does Ann Beal Salamone file Form 4?

Ann Beal Salamone has filed Form 4 at SMTI (Sanara MedTech Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ann Beal Salamone: insider trades and track record | InsiderTell